AMANPREET GILL: Open Payments
NPI 1194035139 · COLUMBUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 5 payments from 4 companies in 2025. Trend: 2023 $588 · 2024 $758 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $182 |
| Lilly USA, LLC | 1 | $123 |
| ABBVIE INC. | 1 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $122 |
Products named: AIRSUPRA, ZEPBOUND, VRAYLAR, FLUMIST QUADRIVALENT.
Industry payments across NJ — which companies pay providers there.
